38 filings
Page 2 of 2
8-K
xkwt3aa
8 Aug 22
Indaptus Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
8:08am
8-K
z1am6
21 Jul 22
Amendments to Articles of Incorporation or Bylaws
4:34pm
8-K
s4hqx
1 Jun 22
Entry into a Material Definitive Agreement
5:02pm
8-K
8wv1inthdmhzu
19 May 22
Indaptus Therapeutics Announces FDA Clearance of Investigational New Drug
7:51am
8-K
jcdxcj19xqabdt
12 May 22
Indaptus Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
8:16am
8-K
gth4e
21 Mar 22
Indaptus Therapeutics Reports Fourth Quarter and Year End 2021 Financial Results and Provides Corporate Update
7:11am
8-K
aumcrc5 7c
1 Feb 22
Departure of Directors or Certain Officers
4:58pm
8-K
t91q6akwcfe
3 Jan 22
Indaptus Therapeutics Announces Appointment of Boyan Litchev, M.D. as Chief Medical Officer
7:38am
8-K
cya x1375y8s
2 Dec 21
Departure of Directors or Certain Officers
8:00am
8-K
2rg0r4 d8j
15 Nov 21
Indaptus Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
7:17am
8-K
s3hw l3hvuvncimrp
16 Aug 21
Unaudited Financial Statements
4:10pm
8-K/A
17gche06
16 Aug 21
Cost Associated with Exit or Disposal Activities
4:05pm
8-K
ud3ev
6 Aug 21
Intec Closes Merger with Decoy Biosystems
5:29pm
8-K
jmvvojjr9fkn
6 Aug 21
Intec Closes Merger with Decoy Biosystems
5:29pm
8-K
1mi0afdx
29 Jul 21
Entry into a Material Definitive Agreement
5:16pm
8-K
fs8p89ujibug brp
23 Jul 21
Departure of Directors or Certain Officers
4:30pm
8-K
rxnt7
16 Jul 21
Other Events
5:11pm
8-K
t0gxl9mj 4e
22 Jun 21
Other Events
9:07am